biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Recent Posting

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 27, 2023 9:48am

132 Views

Post# 35249906

RE:RE:Recent Posting

JD does not own any shares. He hasn't owned any shares in a long time. The amount of time he puts into this stock/message board is quite concerning when you have no financial interest in this stock, right? Hopefully JD is being honest with us as it just does not make any sense.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)